MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program

Go back to MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
MACROGENICS (NASDAQ: MGNX) Delayed: 4.58 --0 (-0%)
Previous Close $4.58    52 Week High $36.11 
Open $4.58    52 Week Low $14.84 
Day High $4.58    P/E 11.74 
Day Low $4.58    EPS $0.39 
Volume 7,235